Hopantenic acid
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Hopantenic acid
- DrugBank Accession Number
- DB14044
- Background
Hopantenic acid (Pantogam) is a central nervous system depressant. Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating) in the absence of addiction, hyperstimulation or withdrawal syndrome. 1
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 233.264
Monoisotopic: 233.126322716 - Chemical Formula
- C10H19NO5
- Synonyms
- Acide hopantenique
- Acido hopantenico
- Acidum hopantenicum
- D-Homopantothenic acid
- Hopantenic acid
- Hopanteninsaeure
- N-pantoyl-GABA
- Pantocalcin
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Product Ingredients
Ingredient UNII CAS InChI Key Calcium hopantenate RQA63PEI5Q 76567-35-6 NNHRASUFFPCRBJ-MIOUZRKOSA-J
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- H473MVB16U
- CAS number
- 18679-90-8
- InChI Key
- SBBDHANTMHIRGW-QMMMGPOBSA-N
- InChI
- InChI=1S/C10H19NO5/c1-10(2,6-12)8(15)9(16)11-5-3-4-7(13)14/h8,12,15H,3-6H2,1-2H3,(H,11,16)(H,13,14)/t8-/m0/s1
- IUPAC Name
- 4-[(2R)-2,4-dihydroxy-3,3-dimethylbutanamido]butanoic acid
- SMILES
- CC(C)(CO)[C@@H](O)C(=O)NCCCC(O)=O
References
- General References
- Voronina TA, Litvinova SA: [Pharmacological effects and clinical application of pantogam and pantogam active]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(8):132-139. doi: 10.17116/jnevro201711781132-139. [Article]
- External Links
- KEGG Drug
- D08042
- ChemSpider
- 26309
- ChEBI
- 134949
- ChEMBL
- CHEMBL2110783
- ZINC
- ZINC000002017228
- Wikipedia
- Hopantenic_acid
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 40.1 mg/mL ALOGPS logP -0.92 ALOGPS logP -1.1 Chemaxon logS -0.77 ALOGPS pKa (Strongest Acidic) 4.37 Chemaxon pKa (Strongest Basic) -2.8 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 4 Chemaxon Polar Surface Area 106.86 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 56.27 m3·mol-1 Chemaxon Polarizability 23.92 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0f89-3790000000-ae627864781af32d325f Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-00lr-4490000000-7da6d4ab16968f6cfb26 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0019-9300000000-e473a2c5e8a46b319180 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9200000000-e5499bd28031adadfbcb Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9100000000-96ca3a410ee4c349fb40 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-000f-9100000000-38241c11836837645aee Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 158.4973903 predictedDarkChem Lite v0.1.0 [M+H]+ 159.6828903 predictedDarkChem Lite v0.1.0 [M+Na]+ 159.0775903 predictedDarkChem Lite v0.1.0
Drug created at May 23, 2018 01:01 / Updated at February 21, 2021 18:54